Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 1998

View Archived Issues

Company Profile: Medarex

Progenics, Roche collaborate on next-generation anti-HIV agents

Interim results reported for ziconotide phase III pain study

Pivotal trial of PROSORBA column in RA stopped early due to favorable results

Japanese marketing agreement announced for Bio-Technology General's hGH

Texas Biotechnology prepares new endothelin modulators

New class of glucocorticoids with an improved pharmacological profile

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Overview of antiviral agents in hepatic disease

Prodrugs of COX-2 inhibitors prepared at Searle

Lilly describes new glycopeptides active against VRE

Phthalazine AMPA receptor antagonists claimed by Schering AG

Modulators of muscarinic receptors claimed by Lilly for AD, psychosis

New proto-oncogene inhibitor isolated from fungus by Schering-Plough

Kyowa Hakko characterizes new MLCK inhibitors from soil fungus

FDA approves first OTC drug for migraine

Schering-Plough discovers dual NK1/NK2 antagonists from fungal strain

Idun licenses novel protein technology from Thomas Jefferson University

TGF-beta mimic discovered in fungal culture by Japanese scientists

PD diagnostic technology available for licensing from NIH

Pacific receives patent allowance for immune system stimulant

Dysentery vaccine technology available for licensing from NIH

CoCensys spins off new company focused on apoptosis screening technology

HIV RT inhibitors available for licensing from NIH

Genzyme General discontinues U.S. development of Sepracoat

New PAF antagonists disclosed by Korean investigators

Three new AIDS vaccine trials examine novel approaches

Novel tumor vaccine technology described by U.S. researchers

FDA clears new indication for Rythmol

Phase III trials of Natrecor BNP now successfully completed

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...